Clinical Trial Update: Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intramyocardial injection of mesenchymal precursor cells in LVAD recipients for safety and efficacy on myocardial function; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure
• Ventricular Dysfunction

Drugs mentioned

• Mesenchymal precursor cells (mesenchymal precursor cells)

Snippet

Sponsor: Annetine Gelijns | Conditions: Heart Failure, Cardiomyopathy | Phase 2 | Status: COMPLETED | Results posted: 2019-11-26